26 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Buyback programs - November 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Buyback programs - december 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Buyback programs - october 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Sales 3rd quarter 2023: 136M€ The Vetoquinol Group posted sales of €136 million in Q3 2023, up +1.3% on a reported basis and +5.1% at constant exchange rates. Over the same period, Vetoquinol recorded a negative currency impact of -€5 million, linked to the Americas and Asia Pacific/Rest of World territories. |
Public releases | ||
Buyback programs - September 2023 (french) Monthly communication regarding buyback programs |
Description of buyback programs | ||
Buyback programs - August 2023 (french) Monthly communication regarding buyback programs |
Description of buyback programs | ||
2023 HALF-YEAR RESULTS Sales: €256m (-5.4% as reported) |
Public releases | ||
Buyback programs - July Monthly communication regarding buyback programs |
Description of buyback programs | ||
Q1 2023 Sales: €145M Vetoquinol recorded sales of €145 million for the first three months of the 2023 financial year, up 7.7% on a reported basis and 7.2% at constant exchange rates. |
Public releases | ||
Availability of the 2022 universal registration document On 13 April 2023, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
Public releases |